Sarepta Therapeutics, Inc. Profile Avatar - Palmy Investing

Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDY…

Biotechnology
US, Cambridge [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Sarepta Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Sarepta Therapeutics, Inc. can't present revenue by segment

End of SRPT's Analysis
CIK: 873303 CUSIP: 803607100 ISIN: US8036071004 LEI: - UEI: -
Secondary Listings
SRPT has no secondary listings inside our databases.